Priority Date: 14.08.12 (US 201261682920P)

ANGIOPOIETIN-LIKE 4 ANTIBODY AND A METHOD OF ITS USE IN CANCER TREATMENT

  • Application ID: EP13829237
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna viering jentschura and partner
operating since 1976
Headquarter in Munich and 5 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 191 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 14.08.2012 - Priority Date (US 201261682920P)
  • 20.02.2014 - Publication A1 (WO2014027959)
  • 24.06.2015 - Publication A1 (EP2885319)

IPC Classification